SCHEMBL6234875

SCHEMBL6234875

CS(=O)(=O)c1ccc(-c2nnc(-c3ccccc3NC(c3ccco3)c3ccco3)[nH]2)cc1

nearest known ligand 0.38

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
EED O75530 1/20 0.38
ADRA2A P08913 1/20 0.38
ADRA2C P18825 1/20 0.38
PDE4D Q08499 1/20 0.38
RBBP4 Q09028 1/20 0.38
SUZ12 Q15022 1/20 0.38
EZH2 Q15910 1/20 0.38
PTGS2 P35354 6/20 0.37
SCD O00767 2/20 0.37
FADS1 O60427 1/20 0.37
WNT3A P56704 1/20 0.36
TNKS2 Q9H2K2 1/20 0.36
CCNE1 P24864 1/20 0.34
CDK2 P24941 1/20 0.34
PTGS1 P23219 1/20 0.34
HSD11B1 P28845 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13605666 0.71 PTGS2 (0.48) ADRA2CPTGS2PTGS1
SCHEMBL6234886 0.69 PTGS2 (0.38) EEDSUZ12EZH2PTGS2SCD
SCHEMBL6234890 0.69 PTGS2 (0.38) PTGS2SCDFADS1WNT3ATNKS2
SCHEMBL4176801 0.69 EED (0.52) EEDADRA2AADRA2CPDE4DRBBP4
SCHEMBL4182630 0.69 BRD4 (0.46) PTGS2SCDFADS1WNT3ATNKS2
SCHEMBL4176803 0.69 PTGS2 (0.40) EEDADRA2AADRA2CPDE4DRBBP4
SCHEMBL4178035 0.68 PDE5A (0.48) PTGS2PTGS1
SCHEMBL4180993 0.62 PTGS2 (0.47) PTGS2SCDCDK2PTGS1
SCHEMBL6234882 0.62 PTGS2 (0.36) PTGS2SCDFADS1WNT3ATNKS2
SCHEMBL10171995 0.62 SCD (0.41) PTGS2SCDWNT3ATNKS2PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005004818-A2 HETEROCYCLIC COMPOUNDS AND THEIR USE AS ANTICANCER AGENTS IMCLONE SYSTEMS INCORPORATED (US) 2005-01-20 WO disclosed